mesoglycan
Animal productexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
1
Earliest trial started May 1, 2013 (NCT02254850)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 2 Sponsor(trial)
Indications
Approved for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- mediolanum
- mesoglycan
- mesoglycan
- prisma
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06101992 | N/A | Jan 1, 2024 | Societa Italiana di Chirurgia ColoRettale |
| NCT03428711 | Phase 2 | Mar 26, 2018 | Associazione Quovadis |
| NCT02254850 | Phase 4 | May 1, 2013 | University of Naples Frederico II |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Associazione Quovadis | For profit | 1 | 1 | 1 | 2018 |
| Societa Italiana di Chirurgia ColoRettale | Academic/Hospital | 1 | 1 | 1 | 2024 |
| University of Naples Frederico II | Academic/Hospital | 1 | 1 | 1 | 2013 |
3 organizations
Page 1 / 1